Elsevier,
Privileged Scaffolds in Drug Discovery
2023, Pages 377-390
This content aligns with Goal 3: Good Health and Wellbeing by discussing the medical applications and limitations of five US Food and Drug Administration–approved INSTIs for the treatment of HIV/AIDS and preexposure prophylaxis for HIV-1.
Elsevier,
Brain Responses to Auditory Mismatch and Novelty Detection
Predictive Coding from Cocktail Parties to Auditory-Related Disorders
2023, Pages 221-269
This content aligns with Goal 3: Good Health and Wellbeing and Goal 10: Reduced Inequalities by highlighting the differences between low- and high-functioning ASD and age dependence of ERP findings in ASD, ADHD, and dyslexia; the effects of language impairment; and the role of ERPs in diagnosing between ASD and ADHD.
Psychosocial Experiences and Adjustment of Migrants Coming to the USA, 2023, Pages 41-51
This content aligns with Goal 3: Good Health as well as Goal 17: Partnership for the goals by reviewing the psychological factors and psychological issues that migrants face during immigration and adjustment.
Psychosocial Experiences and Adjustment of Migrants Coming to the USA, 2023, Pages 101-110
This content aligns with Goal 3: Good Health as well as Goal 17: Partnership for the goals by reviewing the psychological factors and psychological issues that children and youth refugees and immigrants face.
Elsevier,
Negative Emissions Technologies for Climate Change Mitigation, 2023, pages 1-18
This chapter advances UN SDG goals 12 and 13 by providing a historical perspective of the warming effect of carbon dioxide in the atmosphere, describes our growing understanding of climate change, the parallel development of Earth-system modeling capabilities, the Paris Agreement and the need to transition to nonfossil energy and the decarbonization of the global economy
Elsevier,
Brain Responses to Auditory Mismatch and Novelty Detection, First Edition, 2023, pp 271-314
This chapter advances the UN SDG goals 3 and 17 understanding whether decreasing network connectivity in aging is independent of changes across cognitive networks or is accelerated by mild cognitive impairment and AD.
